Search - tctmd.com

Displaying 381 - 400 of 1107

Sort: Relevancy | Date

Presentation THT 2025

Evidence Is Getting STRONGer That Rapid GDMT Uptitration After an AHF Event Is Effective Regardless of LVEF

Presenter: Gad Cotter

February 11, 2025

Presentation THT 2025

Renal Dysfunction as a Primary Mechanism of Symptoms in (Most) Patients With HFpEF

Presenter: Jeffrey Testani

February 11, 2025

Presentation THT 2025

Comprehensive Mapping of Exercise Hemodynamic Responses and Multi-Organ System Reserve Capacity in HFpEF and Implications for Individualized Management

Presenter: Isabela Landsteiner

February 11, 2025

Presentation THT 2025

Assessing the Impact of Hospital Volume Thresholds on In-Hospital Mortality Among Heart Transplant Patients: An Analysis of the National Inpatient Sample (2017-2021)

Presenter: Viet Nghi Tran

February 11, 2025

Presentation THT 2025

Increasing Reach: Using TeleHealth to Get STRONGer

Presenter: Daniel Bensimhon

February 11, 2025

Presentation THT 2025

Mechanisms by Which Cardiometablic Drugs Help People Feel Better

Presenter: Barry Borlaug

February 11, 2025

Presentation THT 2025

Increasing Access: Reducing Referral Delay in Ambulatory Advanced HF Patients

Presenter: Nir Uriel

February 11, 2025

News Conference News THT 2024

Smart Scale Better at Predicting HF Events Than Weight-Based Monitoring

Michael O'Riordan

March 11, 2024

News Conference News THT 2024

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Michael O'Riordan

March 08, 2024

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

MicroRNA in Cardiac Transplantation: Biomarkers With Therapeutic Potential

Presentation THT 2024

MicroRNAs in Cardiac Transplantation: Biomarkers with Therapeutic Potential

Presenter: Palak Shah

March 06, 2024

Presentation THT 2024

Ex Vivo Gene Therapy in Cardiac Allografts

Presenter: Dawn E. Bowles

March 06, 2024

Presentation THT 2024

Designing a Bionic Heart

Presenter: Ellen Roche

March 06, 2024

Presentation THT 2024

3D-Bioprinted Human Tissue and the Path Towards Clinical Translation

Presenter: Adam W. Feinberg

March 06, 2024

Presentation THT 2024

Xeno-Transplant: Where Do We Go From Here?

Presenter: Richard Pierson

March 06, 2024

Presentation THT 2024

Xeno-Transplant: How We Got Here

Presenter: Albert J. Hicks

March 06, 2024

Presentation THT 2024

Metabolic Modulation in Ex-Vivo Perfusion Models: Are We There Yet?

Presenter: Eduardo Rame

March 06, 2024

Presentation THT 2024

DCD with Organ Care System (OCS) versus DCD Normothermic Regional Perfusion (NRP)

Presenter: Nader Moazami

March 06, 2024

Presentation THT 2024

New Endpoints and Experimental Designs for Devices for Chronic Heart Failure (Breakthrough)

Presenter: William T. Abraham

March 06, 2024

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

Advertisement

Evidence Is Getting STRONGer That Rapid GDMT Uptitration After an AHF Event Is Effective Regardless of LVEF

Renal Dysfunction as a Primary Mechanism of Symptoms in (Most) Patients With HFpEF

Comprehensive Mapping of Exercise Hemodynamic Responses and Multi-Organ System Reserve Capacity in HFpEF and Implications for Individualized Management

Assessing the Impact of Hospital Volume Thresholds on In-Hospital Mortality Among Heart Transplant Patients: An Analysis of the National Inpatient Sample (2017-2021)

Increasing Reach: Using TeleHealth to Get STRONGer

Mechanisms by Which Cardiometablic Drugs Help People Feel Better

Increasing Access: Reducing Referral Delay in Ambulatory Advanced HF Patients

Smart Scale Better at Predicting HF Events Than Weight-Based Monitoring

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

MicroRNAs in Cardiac Transplantation: Biomarkers with Therapeutic Potential

Ex Vivo Gene Therapy in Cardiac Allografts

Designing a Bionic Heart

3D-Bioprinted Human Tissue and the Path Towards Clinical Translation

Xeno-Transplant: Where Do We Go From Here?

Xeno-Transplant: How We Got Here

Metabolic Modulation in Ex-Vivo Perfusion Models: Are We There Yet?

DCD with Organ Care System (OCS) versus DCD Normothermic Regional Perfusion (NRP)

New Endpoints and Experimental Designs for Devices for Chronic Heart Failure (Breakthrough)

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content